Skip to main content
SpringerLink
Log in
Book cover

Cognitive Screening Instruments pp 315–339Cite as

The Usage of Cognitive Screening Instruments: Test Characteristics and Suspected Diagnosis

  • Chapter

Abstract

Many cognitive screening instruments have been described in the literature over the past 40 years or so, and these tests find application around the world. However, this superabundance may be bewildering for the clinician approaching a patient with cognitive complaints. Appropriate test selection may depend on a variety of factors related to the particular clinical situation, including, but not limited to, the setting in which cognitive assessment is undertaken (e.g. primary or secondary care settings), the time available to perform testing, the requirement to test general or specific cognitive functions, and the availability of informants. Although many neurological and general medical disorders of varying etiology (neurodegenerative, vascular, inflammatory, endocrine, structural, infective, psychiatric) may cause cognitive impairment, most cognitive disorders in specialist settings result from a relatively small number of conditions, such as Alzheimer’s disease, vascular dementia/vascular cognitive impairment, Parkinson’s disease dementia and dementia with Lewy bodies (DLB), and frontotemporal lobar degeneration syndromes. Clinical suspicion of these entities based on clinical (including informant) history and physical examination may determine which cognitive screening instruments are most appropriately used, as in the investigation of other neurological disorders.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   159.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972;1:233–8.

    Article  CAS  PubMed  Google Scholar 

  2. Molloy DW, Standish TI, Lewis DL. Screening for mild cognitive impairment: comparing the SMMSE and the ABCS. Can J Psychiatry. 2005;50:52–8.

    Article  PubMed  Google Scholar 

  3. Standish TI, Molloy DW, Cunje A, Lewis DL. Do the ABCS 135 short cognitive screen and its subtests discriminate between normal cognition, mild cognitive impairment and dementia? Int J Geriatr Psychiatry. 2007;22:189–94.

    Article  PubMed  Google Scholar 

  4. Sebaldt R, Dalziel W, Massoud F, et al. Detection of cognitive impairment and dementia using the animal fluency test: the DECIDE study. Can J Neurol Sci. 2009;36:599–604.

    Article  PubMed  Google Scholar 

  5. Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA. Designing a Brief Alzheimer Screen (BAS). J Alzheimers Dis. 2003;5:391–8.

    Article  PubMed  Google Scholar 

  6. Mansbach WE, Macdougall EE, Rosenzweig AS. The Brief Cognitive Assessment Tool (BCAT): a new test emphasizing contextual memory, executive functions, attentional capacity, and the prediction of instrumental activities of daily living. J Clin Exp Neuropsychol. 2012;34:183–94.

    Article  PubMed  Google Scholar 

  7. Mansbach WE, Macdougall EE. Development and validation of the short form of the Brief Cognitive Assessment Tool (BCAT-SF). Aging Ment Health. 2012;16:1065–71.

    Article  PubMed  Google Scholar 

  8. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale (GDS) for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136–9.

    Article  CAS  PubMed  Google Scholar 

  9. Saliba D, Buchanan J, Edelen MO, et al. MDS 3.0: brief interview for mental status. J Am Med Dir Assoc. 2012;13:611–7.

    Article  PubMed  Google Scholar 

  10. Brookes RL, Hannesdottir K, Lawrence R, Morris RG, Markus HS. Brief Memory and Executive Test: evaluation of a new screening test for cognitive impairment due to small vessel disease. Age Ageing. 2012;41:212–8.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Huppert FA, Brayne CA, Gill C, et al. CAMCOG – a concise neuropsychological test to assist dementia diagnosis: sociodemographic determinants in an elderly population sample. Br J Clin Psychol. 1995;34:529–41.

    Article  PubMed  Google Scholar 

  12. Pattie AH, Gilleard CJ. A brief psychogeriatric assessment schedule. Validation against psychiatric diagnosis and discharge from hospital. Br J Psychiatry. 1975;127:489–93.

    Article  CAS  PubMed  Google Scholar 

  13. Kiernan RJ, Mueller J, Langston JW, Van Dyke C. The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med. 1987;107:481–5.

    Article  CAS  PubMed  Google Scholar 

  14. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6:45–58.

    Article  CAS  PubMed  Google Scholar 

  15. Swearer JM, Drachman DA, Li L, Kane KJ, Dessureau B, Tabloski P. Screening for dementia in “real world” settings: the cognitive assessment screening test: CAST. Clin Neuropsychol. 2002;16:128–35.

    Article  PubMed  Google Scholar 

  16. Jacobs JW, Bernhard MR, Delgado A, Strain JJ. Screening for organic mental symptoms in the medically ill. Ann Intern Med. 1977;86:40–6.

    Article  CAS  PubMed  Google Scholar 

  17. Belmin J, Pariel-Madjlessi S, Surun P, et al. The cognitive disorders examination (Codex) is a reliable 3-minute test for detection of dementia in the elderly (validation study in 323 subjects). Presse Med. 2007;36:1183–90.

    Article  PubMed  Google Scholar 

  18. Larner AJ. Codex (cognitive disorders examination) for the detection of dementia and mild cognitive impairment. Codex pour la détection de la démence et du mild cognitive impairment. Presse Med. 2013;42:e425–8.

    Article  PubMed  Google Scholar 

  19. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21:1–16.

    Article  PubMed  Google Scholar 

  20. Morris JN, Fries BE, Mehr DR, et al. MDS cognitive performance scale. J Gerontol. 1994;49:M174–82.

    Article  CAS  PubMed  Google Scholar 

  21. Jacqmin-Gadda H, Fabrigoule C, Commenges D, Letenneur L, Dartigues JF. A cognitive screening battery for dementia in the elderly. J Clin Epidemiol. 2000;53:980–7.

    Article  CAS  PubMed  Google Scholar 

  22. Hall KS, Gao S, Emsley CL, Ogunniyi AO, Morgan O, Hendrie HC. Community Screening Interview for Dementia (CSI ‘D’): performance in five disparate studies. Int J Geriatr Psychiatry. 2000;15:521–31.

    Article  CAS  PubMed  Google Scholar 

  23. Ashford JW, Gere E, Bayley PJ. Measuring memory in large group settings using a continuous recognition test. J Alzheimers Dis. 2011;27:885–95.

    PubMed  Google Scholar 

  24. Kawas C, Segal J, Stewart WF, Corrada M, Thal LJ. A validation study of the Dementia Questionnaire. Arch Neurol. 1994;51:901–6.

    Article  CAS  PubMed  Google Scholar 

  25. Ritchie K, Fuhrer R. La mise au point et la validation en France d’un test de dépistage de la démence sénile. Revue de Gériatrie. 1994;19:233–42.

    Google Scholar 

  26. Buschke H, Sliwinski MJ, Kuslansky G, Lipton RB. Diagnosis of early dementia by the Double Memory Test: encoding specificity improves diagnostic sensitivity and specificity. Neurology. 1997;48:989–97.

    Article  CAS  PubMed  Google Scholar 

  27. Carnero-Pardo C, Gurpegui M, Sanchez-Cantaleio E, et al. Diagnostic accuracy of the Eurotest for dementia: a naturalistic, multicenter phase II study. BMC Neurol. 2006;6:15.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Carnero-Pardo C, Saez-Zea C, Montiel-Navarro L, Feria-Vilar I, Gurpegui M. Normative and reliability study of fototest. Neurologia. 2011;26:20–5.

    Article  CAS  PubMed  Google Scholar 

  29. Dubois B, Touchon J, Portet F, Ousset PJ, Vellas B, Michel B. “The 5 words”: a simple and sensitive test for the diagnosis of Alzheimer’s disease [in French]. Presse Med. 2002;31:1696–9.

    CAS  PubMed  Google Scholar 

  30. Fuld PA, Masur DM, Blau AD, Crystal H, Aronson MK. Object-memory evaluation for prospective detection of dementia in normal functioning elderly: predictive and normative data. J Clin Exp Neuropsychol. 1990;12:520–8.

    Article  CAS  PubMed  Google Scholar 

  31. Levin HS, O’Donnell VM, Grossman RG. The Galveston Orientation and Amnesia Test. A practical scale to assess cognition after head injury. J Nerv Ment Dis. 1979;167:675–84.

    Article  CAS  PubMed  Google Scholar 

  32. Imai Y, Hasegawa K. The revised Hasegawa Dementia Scale (HDS-R) – evaluation of its usefulness as a screening test for dementia. J Hong Kong Coll Psychiatry. 1994;4(2):20–4.

    Google Scholar 

  33. Kim KW, Lee DY, Jhoo JH, et al. Diagnostic accuracy of mini-mental status examination and revised Hasegawa dementia scale for Alzheimer’s disease. Dement Geriatr Cogn Disord. 2005;19:324–30.

    Article  CAS  PubMed  Google Scholar 

  34. Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol. 1991;5:125–42.

    Article  Google Scholar 

  35. Frank RM, Byrne GJ. The clinical utility of the Hopkins Verbal Learning Test as a screening test for mild dementia. Int J Geriatr Psychiatry. 2000;15:317–24.

    Article  CAS  PubMed  Google Scholar 

  36. Imon Y. The Imon Cognitive Impairment Screening Test (ICIS): a new brief screening test for mild cognitive impairment or dementia. Nihon Ronen Igakkai Zasshi. 2014;51:356–63.

    Article  PubMed  Google Scholar 

  37. Isaacs B, Akhtar AJ. The set test: a rapid test of mental function in old people. Age Ageing. 1972;1:222–6.

    Article  CAS  PubMed  Google Scholar 

  38. Hopkins R, Kilik L, Day D, Rows C, Hamilton P. The revised Kingston standardized cognitive assessment. Int J Geriatr Psychiatry. 2004;19:320–6.

    Article  PubMed  Google Scholar 

  39. Rami L, Molinuevo JL, Sanchez-Valle R, Bosch B, Villar A. Screening for amnestic mild cognitive impairment and early Alzheimer’s disease with M@T (Memory Alteration Test) in the primary care population. Int J Geriatr Psychiatry. 2007;22:294–304.

    Article  CAS  PubMed  Google Scholar 

  40. Guo QH, Zhou B, Zhao QH, Wang B, Hong Z. Memory and Executive Screening (MES): a brief cognitive test for detecting mild cognitive impairment. BMC Neurol. 2012;12:119.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Buschke H, Kuslansky G, Katz M, et al. Screening for dementia with the memory impairment screen. Neurology. 1999;52:231–8.

    Article  CAS  PubMed  Google Scholar 

  42. Clionsky MI, Clionsky E. Development and validation of the Memory Orientation Screening Test (MOST™): a better screening test for dementia. Am J Alzheimers Dis Other Demen. 2010;25:650–6.

    Article  PubMed  Google Scholar 

  43. Jones BN, Teng EL, Folstein MF, Harrison KS. A new bedside test of cognition for patients with HIV infection. Ann Intern Med. 1993;119:1001–4.

    Article  CAS  PubMed  Google Scholar 

  44. Salib E, McCarthy J. Mental Alternation Test (MAT): a rapid and valid screening tool for dementia in primary care. Int J Geriatr Psychiatry. 2002;17:1157–61.

    Article  PubMed  Google Scholar 

  45. Kahn RL, Goldfarb AI, Ollack M, Peck A. Brief objective measures for the determination of mental status in the aged. Am J Psychiatry. 1960;117:326–8.

    Article  CAS  PubMed  Google Scholar 

  46. Golding E. The Middlesex elderly assessment of mental state. Bury St Edmunds: Thames Valley Test Company; 1989.

    Google Scholar 

  47. Borson S, Scanlan J, Brush M, Vitiliano P, Dokmak A. The Mini-Cog: a cognitive “vital signs” measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15:1021–7.

    Article  CAS  PubMed  Google Scholar 

  48. Borson S, Scanlan JM, Chen P, Ganguli M. The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc. 2003;51:1451–4.

    Article  PubMed  Google Scholar 

  49. Qazi A, Richardson B, Simmons P, et al. The Mini-SIB: a short scale for measuring cognitive function in severe dementia. Int J Geriatr Psychiatry. 2005;20:1001–2.

    Article  PubMed  Google Scholar 

  50. Libon DJ, Massimo L, Moore P, et al. Screening for frontotemporal dementias and Alzheimer’s disease with the Philadelphia Brief Assessment of Cognition: a preliminary analysis. Dement Geriatr Cogn Disord. 2007;24:441–7.

    Article  PubMed  Google Scholar 

  51. Sells R, Larner AJ. The Poppelreuter figure visual perceptual function test for dementia diagnosis. Prog Neurol Psychiatry. 2011;15(2):17–8,20–1.

    Article  Google Scholar 

  52. Warrington EK. The Queen Square screening test for cognitive deficits. London: Institute of Neurology; 1989.

    Google Scholar 

  53. Andersson M, Wiig EH, Minthon L, Londos E. A Quick Test for Cognitive Speed: a measure of cognitive speed in dementia with Lewy bodies. Am J Alzheimers Dis Other Demen. 2007;22:313–8.

    Article  PubMed  Google Scholar 

  54. Kalbe E, Calabrese P, Schwalen S, Kessler J. The Rapid Dementia Screening Test (RDST): a new economical tool for detecting possible patients with dementia. Dement Geriatr Cogn Disord. 2003;16:193–9.

    Article  PubMed  Google Scholar 

  55. Storey JE, Rowland JT, Basic D, Conforti DA, Dickson HG. The Rowland Universal Dementia Assessment Scale (RUDAS): a multicultural cognitive assessment scale. Int Psychogeriatr. 2004;16:13–31 [Erratum Int Psychogeriatr. 2004;16:218].

    Article  PubMed  Google Scholar 

  56. Tariq SH, Tumosa N, Chibnall JT, Perry 3rd MH, Morley JE. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurological disorder – a pilot study. Am J Geriatr Psychiatry. 2006;14:900–10.

    Article  PubMed  Google Scholar 

  57. Solomon PR, Hirschoff A, Kelly B, et al. A 7-minute neurocognitive screening battery highly sensitive to Alzheimer’s disease. Arch Neurol. 1998;55:349–55.

    Article  CAS  PubMed  Google Scholar 

  58. Saxton J, Swihart AA. Neuropsychological assessment of the severely impaired elderly patient. Clin Geriatr Med. 1989;5:531–43.

    CAS  PubMed  Google Scholar 

  59. Belle SH, Mendelsohn AB, Seaberg EC, Ratcliff G. A brief cognitive screening battery for dementia in the community. Neuroepidemiology. 2000;19:43–50.

    Article  CAS  PubMed  Google Scholar 

  60. Robert PH, Schuck S, Dubois B, et al. Screening for Alzheimer’s disease with the short cognitive evaluation battery. Dement Geriatr Cogn Disord. 2003;15:92–8.

    Article  PubMed  Google Scholar 

  61. Koss E, Patterson MB, Ownby R, Stuckey JC, Whitehouse PJ. Memory evaluation in Alzheimer’s disease. Caregivers’ appraisals and objective testing. Arch Neurol. 1993;50:92–7.

    Article  CAS  PubMed  Google Scholar 

  62. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23:433–41.

    Article  CAS  PubMed  Google Scholar 

  63. Kokmen E, Smith GE, Petersen RC, Tangalos E, Ivnik RC. The Short Test of Mental Status. Correlations with standardized psychometric testing. Arch Neurol. 1991;48:725–8.

    Article  CAS  PubMed  Google Scholar 

  64. Zaudig M, Mittelhammer J, Hiller W, et al. SIDAM-A structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. Psychol Med. 1991;21:225–36.

    Article  CAS  PubMed  Google Scholar 

  65. Fong TG, Jones RN, Rudolph JL, et al. Development and validation of a brief cognitive assessment tool: the sweet 16. Arch Intern Med. 2011;171:432–7.

    Article  PubMed  Google Scholar 

  66. Takeda S, Tajime K, Nakagome K. The Takeda Three Colors Combination Test: an easy and quick screening for Alzheimer’s disease. J Am Geriatr Soc. 2010;58:1199–200.

    Article  PubMed  Google Scholar 

  67. Mahoney R, Johnston K, Katona C, Maxmin K, Livingston G. The TE4D-Cog: a new test for detecting early dementia in English speaking populations. Int J Geriatr Psychiatry. 2005;20:1172–9.

    Article  PubMed  Google Scholar 

  68. Froehlich TE, Robison JT, Inouye SK. Screening for dementia in the outpatient setting: the time and change test. J Am Geriatr Soc. 1998;46:1506–11.

    Article  CAS  PubMed  Google Scholar 

  69. Inouye SK, Robison JT, Froehlich TE, Richardson ED. The time and change test: a simple screening test for dementia. J Gerontol A Biol Sci Med Sci. 1998;53:M281–6.

    Article  CAS  PubMed  Google Scholar 

  70. Stanzani Maserati M, Matacena C, Sambati L, et al. The Tree-Drawing Test (Koch’s Baum Test): a useful aid to diagnose cognitive impairment. Behav Neurol. 2015;2015:534681.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Lindeboom J, Schmand B, Tulner L, Walstra G, Jonker C. Visual association test to detect early dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry. 2002;73:126–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Martin-Khan M, Wootton R, Gray L. A systematic review of the reliability of screening for cognitive impairment in older adults by use of standardised assessment tools administered via the telephone. J Telemed Telecare. 2010;16:422–8.

    Article  PubMed  Google Scholar 

  73. Castanho TC, Amorim L, Zihl J, Palha JA, Sousa N, Santos NC. Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments. Front Aging Neurosci. 2014;6:16.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Fukui Y, Yamashita T, Hishikawa N, et al. Computerized touch-panel screening tests for detecting mild cognitive impairment and Alzheimer’s disease. Intern Med. 2015;54:895–902.

    Article  PubMed  Google Scholar 

  75. Burns A, Lawlor B, Craig S. Assessment scales in old age psychiatry. 2nd ed. London: Martin Dunitz; 2004. p. 33–103.

    Book  Google Scholar 

  76. Ashford JW. Screening for memory disorders, dementia and Alzheimer’s disease. Aging Health. 2008;4:399–432.

    Article  Google Scholar 

  77. Tate RL. A compendium of tests, scales, and questionnaires. The practitioner’s guide to measuring outcomes after acquired brain impairment. Hove: Psychology Press; 2010. p. 91–270.

    Google Scholar 

  78. Lorentz WJ, Scanlan JM, Borson S. Brief screening tests for dementia. Can J Psychiatry. 2002;47:723–33.

    Article  PubMed  Google Scholar 

  79. Brodaty H, Low LF, Gibson L, Burns K. What is the best dementia screening instrument for general practitioners to use? Am J Geriatr Psychiatry. 2006;14:391–400.

    Article  PubMed  Google Scholar 

  80. Cordell CB, Borson S, Boustani M, et al. Alzheimer’s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement. 2013;9:141–50.

    Article  PubMed  Google Scholar 

  81. Yokomizo JE, Simon SS, Bottino CM. Cognitive screening for dementia in primary care: a systematic review. Int Psychogeriatr. 2014;26:1783–804.

    Article  PubMed  Google Scholar 

  82. Milne A, Culverwell A, Guss R, Tuppen J, Whelton R. Screening for dementia in primary care: a review of the use, efficacy and quality of measures. Int Psychogeriatr. 2008;20:911–26.

    Article  CAS  PubMed  Google Scholar 

  83. Hussey D, Foy K, Meehean K. Quality of dementia referrals to later life psychiatry service. Psychiatr Bull. 2009;33:154–5.

    Article  Google Scholar 

  84. Fisher CAH, Larner AJ. Frequency and diagnostic utility of cognitive test instrument use by general practitioners prior to memory clinic referral. Fam Pract. 2007;24:495–7.

    Article  CAS  PubMed  Google Scholar 

  85. Menon R, Larner AJ. Use of cognitive screening instruments in primary care: the impact of national dementia directives (NICE/SCIE, National Dementia Strategy). Fam Pract. 2011;28:272–6.

    Article  CAS  PubMed  Google Scholar 

  86. Cagliarini AM, Price HL, Livemore ST, Larner AJ. Will use of the Six-Item Cognitive Impairment Test help to close the dementia diagnosis gap? Aging Health. 2013;9:563–6.

    Article  CAS  Google Scholar 

  87. Ghadiri-Sani M, Larner AJ. Cognitive screening instrument use in primary care: is it changing? Clin Pract. 2014;11:425–9.

    Article  CAS  Google Scholar 

  88. Wojtowicz A, Larner AJ. General Practitioner Assessment of Cognition: use in primary care prior to memory clinic referral. Neurodegener Dis Manag. 2015;5:505–10.

    Google Scholar 

  89. Cannon P, Larner AJ. Errors in the scoring and reporting of cognitive screening instruments administered in primary care. Neurodegener Dis Manag. 2016;6:271–6.

    Google Scholar 

  90. Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.

    Article  CAS  PubMed  Google Scholar 

  91. Brooke P, Bullock R. Validation of a 6 item cognitive impairment test with a view to primary care usage. Int J Geriatr Psychiatry. 1999;14:936–40.

    Article  CAS  PubMed  Google Scholar 

  92. Larner AJ. Speed versus accuracy in cognitive assessment when using CSIs. Prog Neurol Psychiatry. 2015;19(1):21–4.

    Article  Google Scholar 

  93. Larner AJ. Performance-based cognitive screening instruments: an extended analysis of the time versus accuracy trade-off. Diagnostics (Basel). 2015;5:504–12.

    Google Scholar 

  94. Chong MS, Chin JJ, Saw SM, et al. Screening for dementia in the older Chinese with a single question test on progressive forgetfulness. Int J Geriatr Psychiatry. 2006;21:442–8.

    Article  PubMed  Google Scholar 

  95. Department of Health. Using the Commissioning for Quality and Innovation (CQUIN) payment framework. Guidance on the new national goals 2012–13. Department of Health, London; 2012.

    Google Scholar 

  96. Brunet MD, McCartney H, Heath I, et al. There is no evidence base for proposed dementia screening. BMJ. 2012;345:e8588.

    Article  PubMed  Google Scholar 

  97. Aji BM, Larner AJ. Screening for dementia: is one simple question the answer? Clin Med (Lond). 2015;15:111–2.

    Article  Google Scholar 

  98. Hendry K, Hill E, Quinn TJ, Evans J, Stott DJ. Single screening questions for cognitive impairment in older people: a systematic review. Age Ageing. 2015;44:322–6.

    Article  PubMed  Google Scholar 

  99. Barberger-Gateau P, Commenges D, Gagnon M, Letenneur L, Sauvel C, Dartigues JF. Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc. 1992;40:1129–34.

    Article  CAS  PubMed  Google Scholar 

  100. Creavin S, Fish M, Gallacher J, Bayer A, Ben-Shlomo Y. Clinical history for diagnosis of dementia in men: Caerphilly Prospective Study. Br J Gen Pract. 2015;65:e489–99.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Larner AJ. Three simple questions have high utility for diagnosing dementia in the primary care setting. Evid Based Ment Health. 2016;19(3):e13.

    Google Scholar 

  102. Cook C, Fay S, Rockwood K. Verbal repetition in people with mild-to-moderate Alzheimer disease: a descriptive analysis from the VISTA clinical trial. Alzheimer Dis Assoc Disord. 2009;23:146–51.

    Article  PubMed  Google Scholar 

  103. Fukui T, Yamazaki R, Kinno R. Can the “Head-Turning Sign” be a clinical marker of Alzheimer’s disease? Dement Geriatr Cogn Disord Extra. 2011;1:310–7.

    Article  CAS  Google Scholar 

  104. Larner AJ. Head turning sign: pragmatic utility in clinical diagnosis of cognitive impairment. J Neurol Neurosurg Psychiatry. 2012;83:852–3.

    Article  CAS  PubMed  Google Scholar 

  105. Larner AJ. Screening utility of the “attended alone” sign for subjective memory impairment. Alzheimer Dis Assoc Disord. 2014;28:364–5.

    Article  CAS  PubMed  Google Scholar 

  106. Randall A, Larner AJ. La maladie du petit papier: quantitative survey, clinical significance. J Neurol Neurosurg Psychiatry. 2016;87 (accepted).

    Google Scholar 

  107. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 1984;141:1356–64.

    Article  CAS  PubMed  Google Scholar 

  108. Doraiswamy PM, Bieber F, Kaiser L, et al. The Alzheimer’s Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer’s disease trials. Neurology. 1997;48:1511–7.

    Article  CAS  PubMed  Google Scholar 

  109. Morris J, Heyman A, Mohs R, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology. 1989;39:1159–65.

    Article  CAS  PubMed  Google Scholar 

  110. Mattis S. Dementia rating scale. Windsor: NFER-Nelson; 1992.

    Google Scholar 

  111. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–72.

    Article  CAS  PubMed  Google Scholar 

  112. Morris J. The CDR: current version and scoring rules. Neurology. 1993;43:2412–4.

    Article  CAS  PubMed  Google Scholar 

  113. Reisberg B, Ferris SH. Brief cognitive rating scale (BCRS). Psychopharmacol Bull. 1988;24:629–36.

    CAS  PubMed  Google Scholar 

  114. Juva K, Sulkava R, Erkinjuntti T, Ylikoski R, Valvanne J, Tilvis R. Usefulness of the Clinical Dementia Rating scale in screening for dementia. Int Psychogeriatr. 1995;7:17–24.

    Article  CAS  PubMed  Google Scholar 

  115. Mitchell AJ, Malladi S. Screening and case-finding tools for the detection of dementia. Part I: evidence-based meta-analysis of multidomain tests. Am J Geriatr Psychiatry. 2010;18:759–82.

    Article  PubMed  Google Scholar 

  116. Mitchell AJ, Malladi S. Screening and case-finding tools for the detection of dementia. Part II: evidence-based meta-analysis of single-domain tests. Am J Geriatr Psychiatry. 2010;18:783–800.

    Article  PubMed  Google Scholar 

  117. Malloy PF, Cummings JL, Coffey CE, et al. Cognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 1997;9:189–97.

    Article  CAS  PubMed  Google Scholar 

  118. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1143–53.

    Article  CAS  PubMed  Google Scholar 

  119. Waldemar G, Dubois B, Emre M, et al. Recommendations for the diagnosis and management of Alzheimer’s disease and other disorders associated with dementia. Eur J Neurol. 2007;14:e1–26.

    Article  CAS  PubMed  Google Scholar 

  120. Cummings JL, Mega MS, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–14.

    Article  CAS  PubMed  Google Scholar 

  121. Wedderburn C, Wear H, Brown J, et al. The utility of the Cambridge Behavioural Inventory in neurodegenerative disease. J Neurol Neurosurg Psychiatry. 2008;79:500–3.

    Article  CAS  PubMed  Google Scholar 

  122. Hancock P, Larner AJ. Cambridge Behavioural Inventory for the diagnosis of dementia. Prog Neurol Psychiatry. 2008;12(7):23–5.

    Article  Google Scholar 

  123. Wear HJ, Wedderburn CJ, Mioshi E, et al. The Cambridge behavioural inventory revised. Dement Neuropsychol. 2008;2:102–7.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Ferman TJ, Smith GE, Boeve BF, et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology. 2004;62:181–7.

    Article  CAS  PubMed  Google Scholar 

  125. Larner AJ. Can the informant Fluctuation Composite Score help in the diagnosis of synucleinopathies? A pragmatic study. Int J Geriatr Psychiatry. 2012;27:1094–5.

    Article  CAS  PubMed  Google Scholar 

  126. Larner AJ. Dementia in clinical practice: a neurological perspective. Pragmatic studies in the Cognitive Function Clinic. 2nd ed. London: Springer; 2014.

    Book  Google Scholar 

  127. Mitchell AJ. Is it time to separate subjective cognitive complaints from the diagnosis of mild cognitive impairment? Age Ageing. 2008;37:497–9.

    Article  PubMed  Google Scholar 

  128. Larner AJ. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of – or as well as – the MMSE? Int Psychogeriatr. 2012;24:391–6.

    Article  CAS  PubMed  Google Scholar 

  129. Hancock P, Larner AJ. Test Your Memory (TYM) test: diagnostic utility in a memory clinic population. Int J Geriatr Psychiatry. 2011;26:976–80.

    Article  CAS  PubMed  Google Scholar 

  130. Kipps CM, Knibb JA, Hodges JR. Clinical presentations of frontotemporal dementia. In: Hodges JR, editor. Frontotemporal dementia syndromes. Cambridge: Cambridge University Press; 2007. p. 38–79 [at 46–47].

    Chapter  Google Scholar 

  131. Larner AJ, Coles AJ, Scolding NJ, Barker RA. The A-Z of neurological practice. A guide to clinical neurology. 2nd ed. London: Springer; 2011.

    Google Scholar 

  132. Kapur N, Pearson D. Memory symptoms and memory performance of neurological patients. Br J Psychol. 1983;74:409–15.

    Article  PubMed  Google Scholar 

  133. Jónsdóttir MK, Adólfsdóttir S, Cortez RD, Gunnarsdóttir M, Gústafsdóttir AH. A diary study of action slips in healthy individuals. Clin Neuropsychol. 2007;21:875–83.

    Article  PubMed  Google Scholar 

  134. Bonello M, Larner AJ. Applause sign: screening utility for dementia and cognitive impairment. Postgrad Med. 2016;128:250–3.

    Article  CAS  PubMed  Google Scholar 

  135. Larner AJ. Neuropsychological neurology: the neurocognitive impairments of neurological disorders. 2nd ed. Cambridge: Cambridge University Press; 2013.

    Book  Google Scholar 

  136. Langdon DW, Amato MP, Boringa J, et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler. 2012;18:891–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  137. Rao SM. A manual for the Brief Repeatable Battery of Neuropsychological Tests in multiple sclerosis. New York: National Multiple Sclerosis Society; 1990.

    Google Scholar 

  138. Benedict RHB, Fischer JS, Archibald CJ. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol. 2002;16:381–97.

    Article  PubMed  Google Scholar 

  139. Calabrese P. Neuropsychology of multiple sclerosis: an overview. J Neurol. 2006;253(Suppl1):I10–5.

    Article  PubMed  Google Scholar 

  140. Benedict RH, Munschauer F, Linn R, et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler. 2003;9:95–101.

    Article  CAS  PubMed  Google Scholar 

  141. Power C, Selnes OA, Grim JA, McArthur JC. HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:273–8.

    Article  CAS  PubMed  Google Scholar 

  142. Sacktor NC, Wong M, Nakasuija N, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005;19:1367–74.

    PubMed  Google Scholar 

  143. Hu X, Zhou Y, Long J, et al. Diagnostic accuracy of the International HIV Dementia Scale and HIV Dementia Scale: a meta-analysis. Exp Ther Med. 2012;4:665–8.

    Article  PubMed  PubMed Central  Google Scholar 

  144. Haddow LJ, Floyd S, Copas A, Gilson RJ. A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale. PLoS One. 2013;8:e61826.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  145. Mahieux F, Michelet D, Manifacier M-J, Boller F, Fermanian J, Guillard A. Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson’s disease. Behav Neurol. 1995;8:15–22.

    Article  CAS  PubMed  Google Scholar 

  146. Larner AJ. Mini-Mental Parkinson (MMP) as a dementia screening test: comparison with the Mini-Mental State Examination (MMSE). Curr Aging Sci. 2012;5:136–9.

    Article  PubMed  Google Scholar 

  147. Rosser AE, Hodges JR. The Dementia Rating Scale in Alzheimer’s disease, Huntington’s disease and progressive supranuclear palsy. J Neurol. 1994;241:531–6.

    Article  CAS  PubMed  Google Scholar 

  148. Donnelly K, Grohman K. Can the Mattis Dementia Rating Scale differentiate Alzheimer’s disease, vascular dementia, and depression in the elderly? Brain Cogn. 1999;39:60–3.

    Google Scholar 

  149. Lukatela K, Cohen RA, Kessler H, et al. Dementia Rating Scale performance: a comparison of vascular and Alzheimer’s dementia. J Clin Exp Neuropsychol. 2000;22:445–54.

    Article  CAS  PubMed  Google Scholar 

  150. Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase. 2005;11:268–73.

    Article  CAS  PubMed  Google Scholar 

  151. Cowppli-Bony P, Fabrigoule C, Letenneur L, et al. Validity of the five-word screening test for Alzheimer’s disease in a population based study [in French]. Rev Neurol (Paris). 2005;161:1205–12.

    Article  CAS  Google Scholar 

  152. Cacho J, Benito-Leon J, Garcia-Garcia R, Fernandez-Calvo B, Vincente-Villardon JL, Mitchell AJ. Does the combination of the MMSE and Clock Drawing Test (Mini-clock) improve the detection of mild Alzheimer’s disease and mild cognitive impairment? J Alzheimers Dis. 2010;22:889–96.

    Article  PubMed  Google Scholar 

  153. Brown J, Pengas G, Dawson K, Brown LA, Clatworthy P. Self administered cognitive screening test (TYM) for detection of Alzheimer’s disease: cross sectional study. BMJ. 2009;338:b2030.

    Article  PubMed  PubMed Central  Google Scholar 

  154. Ehrensperger MM, Berres M, Taylor KI, Monsch AU. Screening properties of the German IQCODE with a two-year time frame in MCI and early Alzheimer’s disease. Int Psychogeriatr. 2010;22:91–100.

    Article  PubMed  Google Scholar 

  155. Takechi H, Dodge HH. Scenery Picture Memory Test: a new type of quick and effective screening test to detect early stage Alzheimer’s disease. Geriatr Gerontol. 2010;10:183–90.

    Google Scholar 

  156. Santos MT, Sougey EB, Alchieri JC. Validity and reliability of the screening test for Alzheimer’s disease with proverbs (STADP) for the elderly. Arq Neuropsiquiatr. 2009;67:836–42.

    Article  PubMed  Google Scholar 

  157. Prestia A, Rossi R, Geroldi C, et al. Validation study of the three-objects-three-places test: a screening test for Alzheimer’s disease. Exp Aging Res. 2006;32:395–410.

    Article  PubMed  Google Scholar 

  158. De Vresse LP, Pradelli S, Massini G, Buscema M, Savare R, Grossi E. The traveling [sic] salesman problem as a new screening test in early Alzheimer’s disease: an exploratory study. Visual problem-solving in AD. Aging Clin Exp Res. 2005;17:458–64.

    Article  Google Scholar 

  159. Jack Jr CR, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  160. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–92.

    Article  PubMed  PubMed Central  Google Scholar 

  161. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270–9.

    Article  PubMed  PubMed Central  Google Scholar 

  162. Lonie JA, Tierney KM, Ebmeier KP. Screening for mild cognitive impairment: a systematic review. Int J Geriatr Psychiatry. 2009;24:902–15.

    Article  PubMed  Google Scholar 

  163. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow HJ. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.

    Article  PubMed  Google Scholar 

  164. Ahmed S, de Jager C, Wilcock G. A comparison of screening tools for the assessment of mild cognitive impairment: preliminary findings. Neurocase. 2012;18:336–51.

    Article  PubMed  Google Scholar 

  165. Larner AJ. Short performance-based cognitive screening instruments for the diagnosis of mild cognitive impairment. Prog Neurol Psychiatry. 2016;20(2):21–6.

    Article  Google Scholar 

  166. O’Caoimh R, Gao Y, McGlade C, et al. Comparison of the quick mild cognitive impairment (Qmci) screen and the SMMSE in screening for mild cognitive impairment. Age Ageing. 2012;41:624–9.

    Article  PubMed  PubMed Central  Google Scholar 

  167. Ehreke L, Luppa M, Konig HH, Riedel-Heller SG. Is the Clock Drawing Test a screening tool for the diagnosis of mild cognitive impairment? A systematic review. Int Psychogeriatr. 2010;22:56–63.

    Article  PubMed  Google Scholar 

  168. Wahlund L-O, Erkinjuntti T, Gauthier S, editors. Vascular cognitive impairment in clinical practice. Cambridge: Cambridge University Press; 2009.

    Google Scholar 

  169. Langa KM, Foster NL, Larson EB. Mixed dementia: emerging concepts and therapeutic implications. JAMA. 2004;292:2901–8.

    Article  CAS  PubMed  Google Scholar 

  170. Graham NL, Emery T, Hodges JR. Distinctive cognitive profiles in Alzheimer’s disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry. 2004;75:61–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  171. de Koning I, Dippel DW, van Kooten F, Koudstall PJ. A short screening instrument for poststroke dementia: the R-CAMCOG. Stroke. 2000;31:1502–8.

    Article  PubMed  Google Scholar 

  172. Ferris SH. General measures of cognition. Int Psychogeriatr. 2003;15(Suppl1):215–7.

    Article  PubMed  Google Scholar 

  173. Dong Y, Sharma VK, Chan BP, et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurol Sci. 2010;299:15–8.

    Article  PubMed  Google Scholar 

  174. Pendlebury ST, Cuthbertson FC, Welch SJ, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke. 2010;41:1290–3.

    Article  PubMed  Google Scholar 

  175. Van Heugten CM, Walton L, Hentschel U. Can we forget the Mini-Mental State Examination? A systematic review of the validity of cognitive screening instruments within one month after stroke. Clin Rehabil. 2015;29:694–704.

    Article  PubMed  Google Scholar 

  176. Te Winkel-Witlox AC, Post MW, Visser-Meily JM, Lindeman E. Efficient screening of cognitive dysfunction in stroke patients: comparison between the CAMCOG and the R-CAMCOG, Mini-Mental State Examination and Functional Independence Measure-cognition score. Disabil Rehabil. 2008;30:1386–91.

    Article  Google Scholar 

  177. Szatmari S, Fekete I, Csiba L, Kollar J, Sikula J, Bereczki D. Screening of vascular cognitive impairment on a Hungarian cohort. Psychiatry Clin Neurosci. 1999;53:39–43.

    Article  CAS  PubMed  Google Scholar 

  178. Magni E, Binetti G, Padovani A, Cappa SF, Bianchetti A, Trabucchi M. The Mini-Mental State Examination in Alzheimer’s disease and multi-infarct dementia. Int Psychogeriatr. 1996;8:127–34.

    Article  CAS  PubMed  Google Scholar 

  179. Hachinski VC, Iliff LD, Zilkha E, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32:632–7.

    Article  CAS  PubMed  Google Scholar 

  180. Moroney JT, Bagiella E, Desmond DW, et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology. 1997;49:1096–105.

    Article  CAS  PubMed  Google Scholar 

  181. Lees RA, Hendry K, Broomfield N, Stott D, Larner AJ, Quinn TJ. Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items. Int J Geriatr Psychiatry. 2016. doi: 10.1002/gps.4568. [Epub ahead of print].

  182. Calderon J, Perry R, Erzinclioglu S, Berrios GE, Dening T, Hodges JR. Perception, attention and working memory are disproportionately impaired in dementia with Lewy body (LBD) compared to Alzheimer’s disease (AD). J Neurol Neurosurg Psychiatry. 2001;70:157–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  183. Downes JJ, Priestley NM, Doran M, Ferran J, Ghadiali E, Cooper P. Intellectual, mnemonic and frontal functions in dementia with Lewy bodies: a comparison with early and advanced Parkinson’s disease. Behav Neurol. 1998;11:173–83.

    Article  PubMed  Google Scholar 

  184. Kalbe E, Calabrese P, Kohn N, et al. Screening for cognitive deficits in Parkinson’s disease with the Parkinson neuropsychiatric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord. 2008;14:93–101.

    Article  PubMed  Google Scholar 

  185. Pagonabarraga J, Kulisevsky J, Llebaria G, et al. Parkinson’s disease-cognitive rating scale: a new cognitive scale specific for Parkinson’s disease. Mov Disord. 2008;23:998–1005.

    Article  PubMed  Google Scholar 

  186. Pagonabarraga J, Kulisevsky J, Llebaria G, et al. PDD-Short Screen: a brief cognitive test for screening for dementia in Parkinson’s disease. Mov Disord. 2010;25:440–6.

    Google Scholar 

  187. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson’s disease. Neurology. 2003;61:1222–8.

    Article  CAS  PubMed  Google Scholar 

  188. Serrano-Dueñas M, Calero B, Serrano S, Serrano M, Coronel P. Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson’s disease. Mov Disord. 2010;25:2555–62.

    Article  PubMed  Google Scholar 

  189. Ala T, Hughes LF, Kyrouac GA, Ghobrial MW, Elble RJ. The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer’s disease. Int J Geriatr Psychiatry. 2002;17:503–9.

    Article  PubMed  Google Scholar 

  190. Larner AJ. Use of MMSE to differentiate Alzheimer’s disease from dementia with Lewy bodies. Int J Geriatr Psychiatry. 2004;19:1209–10.

    Article  Google Scholar 

  191. Rawle M, Larner A. MoCA subscores to diagnose dementia subtypes: initial study. J Neurol Neursurg Psychiatry. 2014;85, e4.

    Article  Google Scholar 

  192. Reyes MA, Lloret SP, Gerscovich ER, Martin ME, Leiguarda R, Merello M. Addenbrooke’s Cognitive Examination validation in Parkinson’s disease. Eur J Neurol. 2009;16:142–7.

    Article  CAS  PubMed  Google Scholar 

  193. Robben SHM, Sleegers MJM, Dautzenberg PLJ, van Bergen FS, ter Bruggen JP, Olde Rikkert MGM. Pilot study of a three-step diagnostic pathway for young and old patients with Parkinson’s disease dementia: screen, test and then diagnose. Int J Geriatr Psychiatry. 2010;25:258–65.

    Article  PubMed  Google Scholar 

  194. Zadikoff C, Fox SH, Tang-Wai DF, et al. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson’s disease. Mov Disord. 2008;23:297–9.

    Article  PubMed  Google Scholar 

  195. Gill DJ, Freshman A, Blender JA, Ravina B. The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson’s disease. Mov Disord. 2008;23:1043–6.

    Article  PubMed  Google Scholar 

  196. Nazem S, Siderowf AD, Duda JE, et al. Montreal cognitive assessment performance in patients with Parkinson’s disease with “normal” global cognition according to mini-mental state examination score. J Am Geriatr Soc. 2009;57:304–8.

    Article  PubMed  Google Scholar 

  197. Mathew R, Bak TH, Hodges JR. Screening for cognitive dysfunction in corticobasal syndrome: utility of Addenbrooke’s cognitive examination. Dement Geriatr Cogn Disord. 2011;31:254–8.

    Article  PubMed  Google Scholar 

  198. Hodges JR, editor. Frontotemporal dementia syndromes. Cambridge: Cambridge University Press; 2007.

    Google Scholar 

  199. Davies M, Larner AJ. Frontotemporal dementias: development of an integrated care pathway through an experiential survey of patients and carers. Int J Care Pathways. 2010;14:65–9.

    Article  Google Scholar 

  200. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55:1621–6.

    Article  CAS  PubMed  Google Scholar 

  201. Castiglioni S, Pelati O, Zuffi M, et al. The Frontal Assessment Battery does not differentiate frontotemporal dementia from Alzheimer’s disease. Dement Geriatr Cogn Disord. 2006;22:125–31.

    Article  PubMed  Google Scholar 

  202. Larner AJ. Can the Frontal Assessment Battery (FAB) help in the diagnosis of behavioural variant frontotemporal dementia? A pragmatic study. Int J Geriatr Psychiatry. 2013;28:106–7.

    Article  CAS  PubMed  Google Scholar 

  203. Kertesz A, Davidson W, Fox H. Frontal Behavioral Inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci. 1997;24:29–36.

    Article  CAS  PubMed  Google Scholar 

  204. Kertesz A, Nadkarni N, Davidson W, Thomas AW. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc. 2000;6:460–8.

    Article  CAS  PubMed  Google Scholar 

  205. Konstantinopoulou E, Aretouli E, Ioannidis P, Karacostas D, Kosmidis MH. Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer’s disease: evidence from the Frontal Behavioral Inventory. Int J Geriatr Psychiatry. 2013;28:939–46.

    Article  PubMed  Google Scholar 

  206. Gleichgerrcht E, Roca M, Manes F, Torralva T. Comparing the clinical usefulness of the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS) and the Frontal Assessment Battery (FAB) in frontotemporal dementia. J Clin Exp Neuropsychol. 2011;33:997–1004.

    Article  PubMed  Google Scholar 

  207. De Deyn PP, Engelborghs S, Saerens J, et al. The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer’s disease. Int J Geriatr Psychiatry. 2005;20:70–9.

    Article  PubMed  Google Scholar 

  208. Leslie FVC, Foxe D, Daveson N, Flannagan E, Hodges JR, Piguet O. FRONTIER Executive Screen: a brief executive battery to differentiate frontotemporal dementia and Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2016;87:831–5.

    Google Scholar 

  209. Larner AJ, Bracewell RM. A new FRONTIER in dementia differential diagnosis? J R Coll Physicians Edinb. 2016;46:172–3.

    Google Scholar 

  210. Rahman S, Sahakian BJ, Hodges JR, Rogers RD, Robbins TW. Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain. 1999;122:1469–93.

    Article  PubMed  Google Scholar 

  211. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50:7–15.

    Article  CAS  PubMed  Google Scholar 

  212. Rogers RD, Everitt BJ, Baldacchino A, et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology. 1999;20:322–39.

    Article  CAS  PubMed  Google Scholar 

  213. Davies RR, Dawson K, Mioshi E, Erzinclioglu S, Hodges JR. Differentiation of semantic dementia and Alzheimer’s disease using the Addenbrooke’s Cognitive Examination (ACE). Int J Geriatr Psychiatry. 2008;23:370–5.

    Article  PubMed  Google Scholar 

  214. Pérez-Martinez D, Porta-Etessam J, Anaya B, Puente-Muñoz AI. Digit span index: a new diagnostic tool to differential diagnosis [sic] between Alzheimer’s disease and frontotemporal dementia. J Neurol. 2006;253(suppl2):II/93 (abstract P364).

    Google Scholar 

  215. Siri S, Benaglio I, Frigerio A, Binetti G, Cappa SF. A brief neuropsychological assessment for the differential diagnosis between frontotemporal dementia and Alzheimer’s disease. Eur J Neurol. 2001;8:125–32.

    Article  CAS  PubMed  Google Scholar 

  216. Walker AJ, Meares S, Sachdev PS, Brodaty H. The differentiation of mild frontotemporal dementia from Alzheimer’s disease and healthy aging by neuropsychological tests. Int Psychogeriatr. 2005;17:57–68.

    Article  PubMed  Google Scholar 

  217. Hutchinson AD, Mathias JL. Neuropsychological deficits in frontotemporal dementia and Alzheimer’s disease: a meta-analytic review. J Neurol Neurosurg Psychiatry. 2007;78:917–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  218. Hort J, O’Brien JT, Gainotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer’s disease. Eur J Neurol. 2010;17:1236–48.

    Article  CAS  PubMed  Google Scholar 

  219. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.

    Article  PubMed  PubMed Central  Google Scholar 

  220. Sorbi S, Hort J, Erkinjuntti T, et al. EFNS/ENS guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol. 2012;19:1159–79, e85–90.

    Article  CAS  PubMed  Google Scholar 

  221. Filippi M, Agosta F, Barkhof F, et al. EFNS task force: the use of neuroimaging in the diagnosis of dementia. Eur J Neurol. 2012;19:e131–40.

    Article  CAS  PubMed  Google Scholar 

  222. Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614–29 [Erratum Lancet Neurol. 2014;13:757].

    Article  PubMed  Google Scholar 

  223. Cullen B, O’Neill B, Evans JJ, Coen RF, Lawlor BA. A review of screening tests for cognitive impairment. J Neurol Neurosurg Psychiatry. 2007;78:790–9.

    Article  PubMed  Google Scholar 

  224. Woodford HJ, George J. Cognitive assessment in the elderly: a review of clinical methods. Q J Med. 2007;100:469–84.

    Article  CAS  Google Scholar 

  225. Larner AJ, Mitchell AJ. A meta-analysis of the accuracy of the Addenbrooke’s Cognitive Examination (ACE) and the Addenbrooke’s Cognitive Examination-Revised (ACE-R) in the detection of dementia. Int Psychogeriatr. 2014;26:555–63.

    Article  PubMed  Google Scholar 

  226. Draganski B, Ashburner J, Hutton C, et al. Regional specificity of MRI contrast parameter changes in normal ageing revealed by voxel-based quantification (VBQ). Neuroimage. 2011;55:1423–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  227. Stonnington CM, Chu C, Kloppel S, et al. Predicting clinical scores from magnetic resonance scans in Alzheimer’s disease. Neuroimage. 2010;51:1405–13.

    Article  PubMed  PubMed Central  Google Scholar 

  228. Larner AJ. Diagnostic test accuracy studies in dementia. A pragmatic approach. London: Springer; 2015.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cognitive Function Clinic, Walton Centre for Neurology and Neurosurgery, Liverpool, UK

    Andrew J. Larner

Authors
  1. Andrew J. Larner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew J. Larner .

Editor information

Editors and Affiliations

  1. Cognitive Function Clinic, Walton Centre for Neurology and Neurosurgery, Liverpool, UK

    A. J. Larner

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Larner, A.J. (2017). The Usage of Cognitive Screening Instruments: Test Characteristics and Suspected Diagnosis. In: Larner, A.J. (eds) Cognitive Screening Instruments. Springer, Cham. https://doi.org/10.1007/978-3-319-44775-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44775-9_15

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44774-2

  • Online ISBN: 978-3-319-44775-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation